AISF position paper on HCV in immunocompromised patients. Issue 1 (January 2019)

• Record Type: Journal Article
• Authors: Marzano, Alfredo; Angelucci, Emanuele; Astegiano, Marco; Baratelli, Chiara; Biancone, Luigi; Bironzo, Paolo; Brancaccio, Giuseppina; Brunetto, Maurizia Rossana; Bruno, Raffaele; Burra, Patrizia; Cabras, Maria Giuseppina; Caraceni, Paolo; Chialà, Claudia; Clemente, Maria Grazia; Colli, Agostino; Daniele, Bruno; De Gasperi, Elisabetta; Di Marco, Vito; Ditto, Maria Chiara; Fagiuoli, Stefano; Ferri, Clodoveo; Gaeta, Giovanni Battista; Grossi, Paolo Antonio; Imperatrice, Barbara; Lampertico, Pietro; Macaluso, Fabio Salvatore; Madonia, Salvatore; Marignani, Massimo; Mazzarelli, Chiara; Mella, Alberto; Missale, Gabriele; Parisi, Simone; Pasulo, Luisa; Puoti, Massimo; Rendina, Maria; Ribaldone, Davide; Rossi, Giuseppe; Toniutto, Pierluigi; Tucci, Alessandra; Vajro, Pietro; Viganò, Mauro; Volpes, Riccardo; Zignego, Anna Linda;
• Is Part Of: Digestive and liver disease. Volume 51:Issue 1(2019)
• Page Start: 10
• Page End: 23
• Publication Date: 2019-01
• Subjects: HCV -- Immunocompromised patients -- Organ transplant; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/j.dld.2018.09.022
• Languages: English
• ISSNs: 1590-8658

Abstract

Abstract: This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.